Advertisement

Topics

Aerpio Pharmaceuticals Announces Inducement Grants

16:30 EST 18 Dec 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO) (“Aerpio”), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today the grant of inducement equity awards to its newly appoi...

Other Sources for this Article

Investor:
Aerpio Pharmaceuticals, Inc.
Michael Rogers, CFO
513-985-1920

NEXT ARTICLE

More From BioPortfolio on "Aerpio Pharmaceuticals Announces Inducement Grants"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...